Cosopt · DIN 02240113 · 2% & 0.5% · Oph Sol
Limited Use, Reason for Use code 310, 393 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 310, 393 required
Write on scriptone applicable Reason for Use code, 310 or 393 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 310, 393
Reason for Use code 310
As second-line therapy for patients who do not have an adequate intraocular pressure lowering response to monotherapy with ophthalmic beta-blocking agents.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 393
For use as initial therapy in an urgent situation (e.g. patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective.
Coverage limit:
LU Authorization Period: Indefinite
Savings card: RxHelp ONE lists Cosopt (read 2026-09-10) — brand-name savings card, free; cannot be combined with another card on the same claim. (rxhelp.ca ↗)
1 brand, same coverage
Cosopt · DIN 02240113
Manufacturer: Elvium Life Sciences; listing date 2000-01-17
Health Canada: Marketed since 2020-08-31 · brand COSOPT · ATC S01ED51 TIMOLOL, COMBINATIONS · form Solution · route Ophthalmic · ingredients DORZOLAMIDE (DORZOLAMIDE HYDROCHLORIDE) 20 MG/ML, TIMOLOL (TIMOLOL MALEATE) 5 MG/ML · company Elvium life sciences · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02240113)
Source record
DIN 02240113: Cosopt
Raw flags: sec12=Y, sec3=Y
Item: 523600098; group id 624; item number 1591; lccId 00087; manufacturer id ELV
Source form: Oph Sol; strength: 2% & 0.5%
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $9.8639; ministry $2.0951
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02240113
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=63627
Interchangeable products
Apo-Dorzo-Timop · DIN 02299615 · $2.0951
Co Dorzotimolol · DIN 02404389 · $2.0951
Dorzolamide-Timolol · DIN 02522020 · $2.0951
Jamp Dorzolamide-Timolol · DIN 02457539 · $2.0951
M-Dorzolamide-Timolol · DIN 02537796 · $2.0951
Med-Dorzolamide-Timolol · DIN 02437686 · $2.0951
Mint-Dorzolamide/Timolol · DIN 02443090 · $2.0951
Riva-Dorzolamide/Timolol · DIN 02441659 · $2.0951
Sandoz Dorzolamide/Timolol · DIN 02344351 · $2.0951
Shortage status: not checked (no credentials)